UNSPSC 51421506: Loteprednol etabonate

This classification denotes a therapeutic glucocorticoid with the molecular formula C24H31ClO7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YEH1EZ96K6, chemically known as chloromethyl 17a-ethoxycarbonyloxy-11b-hydroxyandrosta-1,4-diene-3-one-17b-carbo but more generally known as loteprednol etabonate, which bears US NIH Compound Identifier 54808. European Medicines Agency schedules Loteprednol etabonate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14390MIG.

UNSPSC 51421506 Loteprednol etabonate, a Commodity code, nominally covers ophthalmic corticosteroid pharmaceuticals; however, the recent state and local procurement activity indexed under this code does not reflect that scope. The single recent opportunity on record is Seminole County, Florida's IFB for naloxone and drug deactivation systems—products entirely outside the loteprednol etabonate therapeutic class and pharmaceutical packaging. The mismatch suggests either a cataloging error in the source system or a systematic tagging issue that does not reflect actual commodity purchasing under this code. No state or local procurement activity for loteprednol etabonate itself appears in the recent-opportunities block.

The one indexed opportunity, Seminole County's IFB 60459723LAS (posted June 30, 2026, with response due July 26, 2023—note the date discrepancy in the source), sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The solicitation required electronic bid submission, E-Verify compliance, drug-free workplace certification, and specific insurance coverage; potential FEMA funding introduced federal compliance obligations. Given the absence of relevant recent opportunities and the clear mismatch between the code's nominal pharmaceutical scope and actual solicitation activity, this code warrants close monitoring for catalog corrections or recoding before pursuing it as a business development target.